Navigation Links
SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
Date:10/28/2008

nd ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit http://www.senomyx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: the capabilities and potential for Senomyx's new flavor ingredient; and Senomyx's ability to continue to meet the goals set forth in its collaboration with The Coca-Cola Company. Risks that contribute to the uncertain nature of the forward-looking statements include: Senomyx is dependent on its product discovery and development collaborators for all of Senomyx's revenue; Senomyx is dependent on its current and any future product discovery and development collaborators to develop and commercialize any flavor ingredients Senomyx may discover; Senomyx may be unable to develop flavor ingredients useful for formulation into products; new flavor ingredients must undergo safety review and not all new flavor ingredients may be safe for their intended uses; Senomyx or its collaborators may be unable to obtain and maintain the regulatory approval required for flavor ingredients to be incorporated into products that are sold; even if Senomyx or its collaborators receive a regulatory approval and incorporate Senomyx flavor ingredients into products, those products may never be commercially successful; and Senomyx's ability to compete in the flavor ingredients market
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
6. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
7. SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: SHPG...ay,announcedthatithassubmittedaMAAtotheEuropeanMed...mereplacementtherapyindevelopment,forthetreatmento...cationforvelaglucerasealfathathasbeensubmitted,wit...,, Basedonaglobalsupplyshortageofthecurrentlyap...
(Date:11/24/2009)...mical Abstracts Service (CAS), the global expert o...t office is now the world,s leading producer of pa...ailed Japan,s patent office, the World Intellectua...tes Patent and Trademark Office (USPTO) for more t...n 2006, and exceeded Japan for the first time on a...
(Date:11/23/2009)...dimensional carbon layer in which the carbon atoms... honeycomb. Carbon nanotubes are rolled-up sheets ...rm graphite. Graphene boasts some very special cha...xcellent thermal conductor, and reconciles such co...In addition, graphene is impermeable to gases, whi...
(Date:11/23/2009)...wire/--ImmuneDesignC or p.(IDC)announcedtodaythatD...r.Carterhasasuccessfultrackrec or dinbiotechnology...OfficeratZymoGenetics,inSeattle,WAandChiefScientif... (Photo: http://www.newscom.com/cgi-bin/prnh/20091...hiefExecutiveOfficercommented,"Iamdelightedtowelco...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Polymer with honeycomb structure 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2
...e-digit sales growth, INDIANAPOLIS, April 21 Eli...inancial results for the first quarter of,2008., ... and a pro forma,basis. Reported results were prep...ing principles (GAAP) and include all sales and ex.... Pro forma results assume the ICOS,acquisition wa...
... England, April 21 Paul Capital,Healthcare and Ve...ve,signed a financing agreement relating to frovat...raine. Under the agreement, Vernalis will receive,...Capital Healthcare and,in return, Paul Capital Hea...Menarini,s payments to Vernalis under their exclus...
...esearchers at MIT Lincoln Laboratory have develope...gens such as anthrax and smallpox in less than thr... PAthogen Notification for THreatening Environment...r any other sensor, said James Harper of Lincoln L...urrent sensors take at least 20 minutes to detect ...
Other Biology Technology:Lilly Reports Solid First-Quarter Results 2Lilly Reports Solid First-Quarter Results 3Lilly Reports Solid First-Quarter Results 4Lilly Reports Solid First-Quarter Results 5Lilly Reports Solid First-Quarter Results 6Lilly Reports Solid First-Quarter Results 7Lilly Reports Solid First-Quarter Results 8Lilly Reports Solid First-Quarter Results 9Lilly Reports Solid First-Quarter Results 10Lilly Reports Solid First-Quarter Results 11Lilly Reports Solid First-Quarter Results 12Lilly Reports Solid First-Quarter Results 13Lilly Reports Solid First-Quarter Results 14Lilly Reports Solid First-Quarter Results 15Lilly Reports Solid First-Quarter Results 16Lilly Reports Solid First-Quarter Results 17Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement 2Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement 3MIT's PANTHER sensor quickly detects pathogens 2
(Date:11/23/2009)... , LIVERMORE, Calif. - By producing some of the h...mineral surfaces, scientists have a deeper underst...tals. This research may lead to a new treatment fo...ch, which appears in the Nov. 23 online edition of...of Sciences , explores how peptides interact with ...
(Date:11/23/2009)... , , BIRMINGHAM, Ala. A new study by Universit... that body-mass index (BMI) and co-existing medica...reased survival observed among African-Americans c...The study is published online Nov. 23 in Cancer ,... finding indicates that although BMI and co-morbid...
(Date:11/23/2009)... , CHAMPAIGN, Ill. Two new studies reveal in unp...other molecules to assemble new proteins and guide.... The studies used molecular dynamics flexible fit...some with two prominent molecular partners. , T...ademy of Sciences , concerns the intimate signalin...
Breaking Biology News(10 mins):Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3One year results from Horizons AMI trial reported at TCT 2009 57842 1One year results from Horizons AMI trial reported at TCT 2009 57842 2One year results from Horizons AMI trial reported at TCT 2009 57842 3One year results from Horizons AMI trial reported at TCT 2009 57842 4Growing outcomes evidence spurs renewed interest in unique heart valve procedure 10008 1Growing outcomes evidence spurs renewed interest in unique heart valve procedure 10008 2New chemically activated antigen could expedite development of HIV vaccine 10004 1New chemically activated antigen could expedite development of HIV vaccine 10004 2New chemically activated antigen could expedite development of HIV vaccine 10004 3New chemically activated antigen could expedite development of HIV vaccine 10004 4
...–killing medication appears to halt the production...st cancer, a new study using tissue cultures sugge...y experiments on breast cancer cells, scientists f...oduction of aromatase, the enzyme implicated in es...t cancer is the most common kind of breast cancer ...
...ionary paths to new therapeutic drugs, as well as ...een created through, of all things, intelligent de...keley National Laboratory (Berkeley Lab) and the U... a technique in which the evolution of an importan...utcome. , "We,ve taken enzymes that are promiscuou...
...checked activity of a cell signaling pathway cruci...se to injury leads to liver cancer, researchers fr... University School of Medicine have found. , Becau...n immature, stem-like liver cells, the discovery o... one of the leading causes of cancer-related death...
Other Biology News:Pain killer fights breast cancer by targeting key enzyme 2Pain killer fights breast cancer by targeting key enzyme 3Intelligently designed molecular evolution 2Intelligently designed molecular evolution 3Liver cancer linked to cellular repair pathway 2Liver cancer linked to cellular repair pathway 3
Goat Anti-Mouse NOV / CCN3 Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
HiTrap NHS-activated HP from GE Healthcare, formerly Amersham Biosciences
Goat Anti-Human Serpin A8 Polyclonal Antibody, Unconjugated from R&D Systems
Biology Products: